Fierce Biotech Names Proxygen a “Fierce 15” Biotech Company of 2023

VIENNA, Austria, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced that Fierce Biotech has named it as one of 2023’s “Fierce 15” biotechnology companies. The annual special report features the most innovative and promising early-stage biotechnology companies in the industry. “It is an incredible honor to be recognized as one of the Fierce 15 biotech companies for 2023,” said Bernd Boidol, Ph.D., chief executive offi

Introducing Fierce Biotech's 2023 Fierce 15

Jacob Perrett posted on LinkedIn

Fierce Biotech's 2022 Fierce 15

Proxygen LinkedIn

Introducing Fierce Biotech's 2023 Fierce 15

News - Proxygen

2023“生物技术猛公司”榜单火热出炉，它们带来了哪些突破? - 知乎

Chris Jenkins على LinkedIn: #genetherapy #community

见时知几：2023年Fierce15药企预示着哪些投资趋势- 知乎

见时知几：2023年Fierce15药企预示着哪些投资趋势- 知乎

Jacob Perrett on LinkedIn: What does July's biotech funding reveal

Mark Federici on LinkedIn: Fierce Biotech Names Proxygen a “Fierce

Fierce Biotech on LinkedIn: Researchers predict Alzheimer's